MapLight Therapeutics MPLT
NASDAQ MPLT
$13.89 +0.75 (+5.71%)
As of: Sep 4, 2026 · 2:25 PM EDT

MapLight Therapeutics (MPLT) EPS (Diluted) (2024 - 2026)

Analysis

MapLight Therapeutics (MPLT) EPS (Diluted) (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Vertex Pharmaceuticals 138.87 Bn 131.01 Bn 2.84 Bn 4.31
2 Regeneron Pharmaceuticals 85.57 Bn 77.57 Bn 3.93 Bn 12.23
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn 7.15
4 Moderna 58.19 Bn 53.05 Bn 52.00 Mn -1.96
5 Revolution Medicines 44.07 Bn 44.07 Bn - -3.06
6 BeOne Medicines 39.99 Bn 34.89 Bn 1.53 Bn 2.05
7 Alnylam Pharmaceuticals 35.38 Bn 32.07 Bn 992.69 Mn 1.19
8 Royalty Pharma 28.42 Bn 27.58 Bn - 0.15
9 Insmed 27.41 Bn 26.25 Bn 358.27 Mn -0.06
10 MapLight Therapeutics 631.50 Mn 631.50 Mn - -1.35
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.35
Dec 31, 2025 -9.32
Sep 30, 2025 -37.86
Jun 30, 2025 -39.28
Dec 31, 2024 -29.72
Sep 30, 2024 -26.13